-transparent.png){kind=logo}
The present paper investigated histological changes in the myocardium in two potential beta-adrenolytic agents, 4-[3-isopropylamino-2-hydroxypropoxy]-3-[propoxymethyl]acetophenone and 4-[3-isopropylamino-hydroxypropoxy]-3-[pentyloxymethyl]acetophenon e after intravenous administration in doses of 8 mg/kg and 24 mg/kg. It results from the found data that in both agents in the doses used there are no necrotic changes in the myocardium and the values of the impairment range within the 1st degree of Zbinden's classification, comparable to the standard metipranolol.
Related Publications
R Cizmáriková, and
E Pazin, and
Hricková
July 1994,
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
R Cizmáriková, and
E Pazin, and
Hricková
May 1994,
Die Pharmazie,
R Cizmáriková, and
E Pazin, and
Hricková
January 1988,
Drugs under experimental and clinical research,
R Cizmáriková, and
E Pazin, and
Hricková
February 1990,
Die Pharmazie,
R Cizmáriková, and
E Pazin, and
Hricková
April 1968,
L'union medicale du Canada,
R Cizmáriková, and
E Pazin, and
Hricková
July 1982,
Ceskoslovenska farmacie,
R Cizmáriková, and
E Pazin, and
Hricková
July 1985,
Psychiatrie, Neurologie, und medizinische Psychologie,
R Cizmáriková, and
E Pazin, and
Hricková
September 1982,
Ceskoslovenska farmacie,
R Cizmáriková, and
E Pazin, and
Hricková
April 1993,
Ceskoslovenska farmacie,
R Cizmáriková, and
E Pazin, and
Hricková
May 1967,
Der Anaesthesist,
